The Maryland Stem Cell Consortium was founded jointly by Paragon and The University of Maryland to accelerate the translation of new stem cell therapies into the clinic and provide stem cell based tools for drug development. Through cooperative efforts, the Consortium brings together Expertise, Service and Training for stem cell technologies.
Paragon has received funding from the Department of Business and Economic Development (DBED), support from the University of Maryland Center for Regenerative Medicine, and other Maryland companies to establish a STEM CELL CORE FACILITY to serve the needs of Public and Private institutions.
Contact us to learn more about The Maryland Stem Cell Consortium—or to speak with a Ph.D.-level scientist about Paragon’s Stem Cell Services.
More about Stem Cell Technologies »